Related Experiment Video
Updated: Jun 18, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
HDAC inhibition radiosensitizes human normal tissue cells and reduces DNA Double-Strand Break repair capacity
Jan C Purrucker1, Andreas Fricke, Mei Fang Ong
1Division of Immunotherapy and Gene Therapy, Department of Internal Medicine I, José Carreras Research Center, Saarland University Medical Center, Homburg/Saar, Germany.
Abstract:
HDAC inhibitors (HDACi) are gaining increasing attention in the treatment of cancer, particularly in view of their therapeutic effectiveness and assumed mild toxicity profile. While numerous studies have investigated the role of HDACi in tumor cells, little is known about their effects on normal tissue cells. We studied the effect of suberoylanilide hydroxamic acid (SAHA), MS275, sodium-butyrate and valproic acid in healthy human fibroblasts and found HDACi-treatment to go along with increased radiosensitivity and reduced DSB repair capacity. In view of the potential genotoxic effects of HDACi-treatment, particularly when being administered long-term for chronic disease or when given to children, to women of childbearing age or their partners or in combination with radiotherapy, an extensive education of patients and prescribing physicians as well as a stringent definition of clinical indications is urgently required.
Insights
Histone deacetylase inhibitors (HDACi) increase cancer cell radiosensitivity but impair DNA repair in healthy fibroblasts. This highlights potential genotoxic risks, necessitating careful patient selection and education for HDACi cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Histone deacetylase inhibitors (HDACi) show promise in cancer treatment due to efficacy and low toxicity.
- Limited research exists on HDACi effects on normal tissue cells.
Purpose of the Study:
- To investigate the impact of HDAC inhibitors on healthy human fibroblasts.
- To assess the genotoxic potential of HDAC inhibitors in normal cells.
Main Methods:
- Treatment of healthy human fibroblasts with suberoylanilide hydroxamic acid (SAHA), MS275, sodium butyrate, and valproic acid.
- Evaluation of radiosensitivity and DNA double-strand break (DSB) repair capacity.
Main Results:
- HDAC inhibitor treatment led to increased radiosensitivity in normal fibroblasts.
- A reduced capacity for DSB repair was observed in HDACi-treated cells.
Conclusions:
- HDAC inhibitors may possess genotoxic effects on normal tissues.
- Potential risks necessitate stringent clinical indications and patient/physician education, especially for long-term use or combination therapies.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Other Unique Bacteria
Fixing Double-strand Breaks
Inhibition of Cdk Activity

